ALMR Alamar Biosciences, Inc.

CIK 0002104204 3 ready 8-Ks latest May 8, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 1 filings / 30d vs 0 baseline

Ready 8-Ks 3

Latest filing July 15, 2026, 4:04 PM ET

Top materiality 0.85

Event mix leadership ×1 · earnings ×1 · other_material ×1

Sentiment 2 pos · 1 neg · 0 neu

Latest earnings reported 2026-Q1

Recent 8-K filings for ALMR

Highest-materiality recent filing

Alamar Biosciences closes IPO of 12.9M shares at $17.00, raising ~$219.9M

April 20, 2026, 7:59 PM ET other material materiality 0.85 positive item 5.03 item 8.01 item 9.01 ◈ Governance Changes ×2

Completed IPO of 12,937,500 shares of common stock at $17.00 per share, including full exercise of underwriters' option for 1,687,500 shares.
Aggross gross proceeds of approximately $219.9 million before underwriting discounts and offering expenses.

May 8, 2026, 7:59 PM ET earnings materiality 0.78 positive item 2.02 item 9.01 ◈ Earnings Releases

Alamar Q1 revenue doubled to $26.0M; net loss $21.3M on convertible note remeasurement

Total revenue $26.0M, +99% YoY; consumable revenue surged 178% to $14.0M.
April 20, 2026, 7:59 PM ET other material materiality 0.85 positive item 5.03 item 8.01 item 9.01 ◈ Governance Changes ×2

Alamar Biosciences closes IPO of 12.9M shares at $17.00, raising ~$219.9M

Completed IPO of 12,937,500 shares of common stock at $17.00 per share, including full exercise of underwriters' option for 1,687,500 shares.

2026-Q1 EPS reported -$1.74 filing →

Max materiality 0.85 · Median 0.78 · Most common event leadership

2 positive 1 negative 0 neutral